Biotalys Announces New Dates for the Publication of its 2025 Annual Report and for its Annual Shareholders Meeting
View original at globenewswire.comBiotalys Announces New Dates for the Publication of its 2025 Annual Report and for its Annual Shareholders Meeting Ghent, BELGIUM, March 24, 2026 (GLOBE NEWSWIRE) -- Press release – regulated information Biotalys (Euronext - BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrol solution…
What we drew from this source
The claims Via News extracted from this document. We point to the source; we don't replace it.
The company will require additional funds beyond May 2026 to meet its capital and expenditure needs and ensure its going concern even if the intended restructuring would be completed
60% confidenceThe company currently believes that the updated timeline will allow sufficient time to progress financing discussions, ensuring that the annual report and financial figures correctly reflect a more advanced status thereof
60% confidenceFinancing might eventually not be available or if available, might result in an important dilution of existing shareholders or not be available on commercially favourable terms
60% confidenceNo binding financing proposals are yet obtained
60% confidenceThe updated timeline will allow sufficient time to progress financing discussions, ensuring that the annual report and financial figures correctly reflect a more advanced status thereof
60% confidenceNo binding financing proposals are yet obtained
60% confidenceNo binding financing options or proposals are obtained by the company as of March 24, 2026
60% confidenceBiotalys confirms it is in ongoing discussions with existing and new investors to obtain additional financing to support its operations in going concern
60% confidenceThe company has a cash runway until end of May 2026
60% confidenceThe company will require additional funds beyond May 2026 to meet its capital and expenditure needs and ensure its going concern even if the intended restructuring of the company would be completed
60% confidenceSuch financing might eventually not be available or if available, might result in an important dilution of existing shareholders or, in general, not be available on commercially favourable terms
60% confidenceThe company has a cash runway until end of May 2026
60% confidenceBiotalys does not have sufficient working capital to cover the working capital needs for a period of at least 12 months
60% confidenceThe company is in ongoing discussions with existing and new investors to obtain additional financing to support its operations in going concern
60% confidenceBiotalys does not have sufficient working capital to cover the working capital needs for a period of at least 12 months as of the date hereof and only has a cash runway until end of May 2026
60% confidence